During the recent session, Teladoc Health Inc (NYSE:TDOC)’s traded shares were 1.79 million, with the beta value of the company hitting 0.90. At the last check today, the stock’s price was $9.36, reflecting an intraday gain of 3.97% or $0.36. The 52-week high for the TDOC share is $22.54, that puts it down -140.81 from that peak though still a striking 27.78% gain since the share price plummeted to a 52-week low of $6.76. The company’s market capitalization is $1.60B, and the average intraday trading volume over the past 10 days was 5.55 million shares, and the average trade volume was 5.77 million shares over the past three months.
Teladoc Health Inc (TDOC) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 2.61. TDOC has a Sell rating from 0 analyst(s) out of 19 analysts who have looked at this stock. 10 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 9 recommend a Buy rating for it.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Teladoc Health Inc (NYSE:TDOC) trade information
Teladoc Health Inc (TDOC) registered a 3.97% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 3.97% in intraday trading to $9.36, hitting a weekly high. The stock’s 5-day price performance is 9.19%, and it has moved by 7.80% in 30 days. Based on these gigs, the overall price performance for the year is -43.80%. The short interest in Teladoc Health Inc (NYSE:TDOC) is 25.26 million shares and it means that shorts have 4.72 day(s) to cover.
The consensus price target of analysts on Wall Street is $36, which implies an increase of 74.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $9 and $150 respectively. As a result, TDOC is trading at a discount of -1502.56% off the target high and 3.85% off the low.
Teladoc Health Inc (TDOC) estimates and forecasts
Statistics show that Teladoc Health Inc has underperformed its competitors in share price, compared to the industry in which it operates. Teladoc Health Inc (TDOC) shares have gone down -26.78% during the last six months, with a year-to-date growth rate less than the industry average at -300.00% against 8.40.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 1.91%. While earnings are projected to return -334.35% in 2024.
TDOC Dividends
Teladoc Health Inc is due to release its next quarterly earnings on 2025-Feb-18. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Teladoc Health Inc (NYSE:TDOC)’s Major holders
Teladoc Health Inc insiders own 0.82% of total outstanding shares while institutional holders control 80.06%, with the float percentage being 80.72%. BLACKROCK INC. is the largest shareholder of the company, while 558.0 institutions own stock in it. As of 2024-06-30, the company held over 21.61 million shares (or 12.8843% of all shares), a total value of $211.35 million in shares.
The next largest institutional holding, with 17.22 million shares, is of VANGUARD GROUP INC’s that is approximately 10.2643% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $168.38 million.
